Manganese is an essential
metal that becomes toxic at elevated levels. Loss-of-function mutations in SLC30A10, a cell-surface-localized
manganese efflux transporter, cause a heritable
manganese metabolism disorder resulting in elevated
manganese levels and parkinsonian-like movement deficits. The underlying disease mechanisms are unclear; therefore, treatment is challenging. To understand the consequences of loss of SLC30A10 function at the organism level, we generated Slc30a10 knock-out mice. During early development, knock-outs were indistinguishable from controls. Surprisingly, however, after weaning and compared with controls, knock-out mice failed to
gain weight, were smaller, and died prematurely (by ∼6-8 weeks of age). At 6 weeks,
manganese levels in the brain, blood, and liver of the knock-outs were ∼20-60-fold higher than controls. Unexpectedly, histological analyses revealed that the brain and liver of the knock-outs were largely unaffected, but their thyroid exhibited extensive alterations. Because
hypothyroidism leads to growth defects and premature death in mice, we assayed for changes in thyroid and
pituitary hormones. At 6 weeks and compared with controls, the knock-outs had markedly reduced
thyroxine levels (∼50-80%) and profoundly increased
thyroid-stimulating hormone levels (∼800-1000-fold), indicating that Slc30a10 knock-out mice develop
hypothyroidism. Importantly, a low-
manganese diet produced lower tissue
manganese levels in the knock-outs and rescued the phenotype, suggesting that
manganese toxicity was the underlying cause. Our unanticipated discovery highlights the importance of determining the role of thyroid dysfunction in the onset and progression of
manganese-induced disease and identifies Slc30a10 knock-out mice as a new model for studying thyroid biology.